12.07.2015 Views

Sustaining Generic Medicines Markets in Europe

Sustaining Generic Medicines Markets in Europe

Sustaining Generic Medicines Markets in Europe

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Susta<strong>in</strong><strong>in</strong>g</strong> generic medic<strong>in</strong>es markets 9518 GlossaryActive substance: that component of a medic<strong>in</strong>e that gives it its therapeutic effect.ATC classification: a standard for classify<strong>in</strong>g drugs <strong>in</strong>to different groups accord<strong>in</strong>g to the organor system on which they act and their chemical, pharmacological and therapeutic properties.Bio-availability: the amount of an active substance that is absorbed by the organism and thespeed at which this occurs when <strong>in</strong>troduced <strong>in</strong> a given dosage form.Bio-equivalence: bio-equivalent medic<strong>in</strong>es conta<strong>in</strong> the same amount of active substance andhave the same bio-availability when adm<strong>in</strong>istered <strong>in</strong> equal doses under equal conditions.Copy: an off-patent medic<strong>in</strong>e that is neither an orig<strong>in</strong>ator medic<strong>in</strong>e, nor a licensed medic<strong>in</strong>e, nora generic medic<strong>in</strong>e through the Abridged Procedure and has, for example, been approvedthrough the Well-Established Use Procedure. For a copy, bio-equivalence with the orig<strong>in</strong>atormedic<strong>in</strong>e has not been approved.Data exclusivity: the period of time dur<strong>in</strong>g which the application for market<strong>in</strong>g authorisation of ageneric medic<strong>in</strong>e cannot refer to the pre-cl<strong>in</strong>ical and cl<strong>in</strong>ical documentation of the orig<strong>in</strong>atormedic<strong>in</strong>e.Def<strong>in</strong>ed daily dose: the assumed average daily dose of a medic<strong>in</strong>e needed to treat its ma<strong>in</strong><strong>in</strong>dication <strong>in</strong> an adult person weigh<strong>in</strong>g 70 kg.Dosage: amount of a medic<strong>in</strong>e that is adm<strong>in</strong>istered to a patient.<strong>Generic</strong> medic<strong>in</strong>e: a medic<strong>in</strong>al product that has the same qualitative and quantitativecomposition <strong>in</strong> active substances and the same pharmaceutical form as the reference medic<strong>in</strong>alproduct, and whose bio-equivalence with the reference medic<strong>in</strong>al product has been demonstratedby appropriate bio-availability studies (Directive 2004/27/EC). A generic medic<strong>in</strong>e is approvedthrough the Abridged Procedure and marketed by a company other than the orig<strong>in</strong>ator medic<strong>in</strong>ecompany.<strong>Generic</strong> substitution: procedure by which a physician prescribes a specific medic<strong>in</strong>e, but thepharmacist replaces it by a generic medic<strong>in</strong>e that has the same active substance and bioavailabilityas the medic<strong>in</strong>e that is prescribed.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!